Bethesda, MD – The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Melatonin Biology: Actions & Therapeutics.
The 2013 FASEB SRC on Melatonin Biology: Actions & Therapeutics is an important and unique scientific conference where new and exciting discoveries regarding melatonin as a cytoprotective molecule and a physiological marker of circadian phase will be explored in talks, poster sessions, and intensive scientific discussion. This gathering of researchers from around the world to share cutting edge results and to discuss the functions of melatonin and its receptors in illness and health is key for accelerating breakthrough outcomes in melatonin biology and therapeutics.
FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.
In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at SRC@faseb.org. Proposal guidelines can be found at www.faseb.org/SRC.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.